<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

 

LSX USA White 500x 

   STRATEGY, INVESTMENT AND PARTNERING FOR LIFE SCIENCE EXECUTIVES   

 
7 - 8 October 2019 | Convene Convention Center | Boston | USA
#LSXUSA

What is LSX World Congress USA?

The LSX World Congress USA brings together senior life science decision makers. We connect executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

We achieve this via content that showcases and shares the expertise of investors, senior leaders and industry stakeholders. With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, we bring together the people that matter to the future of healthcare.

Meet some of our 2018 speakers

Ivana Magovčević-Liebisch, EVP & Chief Business Officer, Ipsen

Ivana Magovčević-Liebisch

EVP & Chief Business Officer
Ipsen
Noubar Afeyan, Founder and CEO, Flagship Pioneering

Noubar Afeyan

Founder and CEO
Flagship Pioneering
Boris Zaitra, Global Head of M&A, Roche

Boris Zaitra

Global Head of M&A
Roche
Neil Exter, Partner, Third Rock Ventures

Neil Exter

Partner
Third Rock Ventures
Arjun Goyal, Co-Founder and Managing Director, VIDA Ventures

Arjun Goyal

Co-Founder and Managing Director
VIDA Ventures
James Kasuboski, Director, Boehringer

James Kasuboski

Director
Boehringer Ingelheim Venture Fund USA
Michal Silverberg, Managing Director, Novartis Venture Fund

Michal Silverberg

Managing Director
Novartis Venture Fund
Todd Foley, Managing Director, MPM Capital

Todd Foley

Managing Director
MPM Capital
Alexandra Glucksmann, CEO, Cedilla Therapeutics

Alexandra Glucksmann

CEO
Cedilla Therapeutics
Rob Brainin, CEO, WuXI NextCODE

Rob Brainin

CEO
WuXI NextCODE
Michael Sherman, SVP and Chief Medical Officer, Harvard Pilgrim Health Care

Michael Sherman

SVP and Chief Medical Officer
Harvard Pilgrim Health Care
ALEX DE WINTER Managing Director GE VENTURES

Alex de Winter

Managing Director
GE Ventures
PAUL BIONDI SVP Head of BD BRISTOL-MYERS SQUIBB

Paul Biondi

SVP, Strategy and Business Development
Bristol-Myers Squibb
Russ Johannesson, CEO, Glooko

Russ Johannesson

CEO
Glooko
NIGEL SHEAIL Global Head of M&A and BD&L NOVARTIS

Nigel Sheail

Global Head of M&A and BD&L
Novartis
DOUG GIORDANO VP Business Development PFIZER

DOUG GIORDANO

VP Business Development
PFIZER
VIEW ALL 2018 SPEAKERS

Network

Network

Biotech, medtech and deeptech CxOs will be coming to Boston and joined by investors and pharma to address key issues facing their businesses and the wider healthcare sector.

Partner

Partner

1-2-1 partnering is a key focus across the two days. Pre-event all attendees and see who is attending, message each other and book meetings to find investors, investment opportunities and connect with potential partners.

Learn

Learn

Understand the latest trends, forecasts and insights from leading investors, life science executives, pharma BD&L heads and industry KOLs through presentations and more informal workshops and group discussions.

Meet our 2018 partners

 

Citi.jpg
Covington 300x200.jpg
Freshfields Bruckhaus Deringer 300x200.jpg
Goldman Sachs 300x200.jpg
Hogan Lovells Resize.png
LaVoie Health Science.png
Mintz Levin Re-Sized.png
Nasdaq Resize.png
Oppenheimer.jpg
PPD 300x200.jpg
WH2520Lockup2520Color2520(jpg) (1)
LSX Congress USA